News

The U.S. stock market is having a terrific year. The benchmark S&P 500 (SNPINDEX: ^GSPC) is up 16% in 2025 despite economic uncertainty created by President Trump's tariffs. But there could be

For the better part of the last three years, no trend has garnered more investor attention or capital on Wall Street than artificial intelligence (AI). Giving software and systems the tools to make

Don't let IonQ's (NYSE: IONQ) recent sell-off fool you. The stock remains one of the most intriguing opportunities for patient investors.

More importantly, IonQ is still one of the top up-and-coming

Back in 2020 and 2021, many retail investors loaded up on speculative growth stocks at sky-high valuations. That buying frenzy was largely driven by stimulus checks, social media buzz, a fear of

I appreciate that Warren Buffett keeps us guessing. The longtime CEO of Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) is retiring at the end of this month, but he leaves a powerful legacy as one of

In this podcast, Motley Fool analysts Asit Sharma, David Meier, and Tim Beyers:

Don't wait! Be sure to get to your bookstore and pick up a copy of David's Gardner's new book -- Rule Breaker

Astera Labs (NASDAQ: ALAB) has seen its share price soar almost 400% since its initial public offering in 2024. It provides essential components that enable faster processing speeds for artificial

Shares of Taiwan Semiconductor Manufacturing Co. (NYSE: TSM) are up by roughly 54% in 2025 through Dec. 9. The company is experiencing exceptional demand for its cutting-edge process nodes and CoWoS

The holiday season is a great time for retail stocks, but not all of them carry that rally into the new year. And then some retailers continue to post excellent sales numbers regardless of the time

It isn't always obvious that a growth stock will take off and generate massive returns for your portfolio. However, that's one of the reasons why sometimes taking a chance on an up-and-coming stock

The growth in demand for artificial intelligence (AI) systems and hardware has been a significant boon for the leading cloud infrastructure companies, because businesses that want to tap into the

XRP's (CRYPTO: XRP) price set a record high of $3.65 on July 17, 2025. That marked a gain of more than 480% over the previous 12 months. But today, it trades at about $2.

XRP initially rallied as it

Lombard Odier Asset Management (USA) Corp cut its stake in Bausch Health Companies (NYSE:BHC) by 3,334,000 shares in the third quarter, reducing its position by approximately $22,564,800, according

In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When

When a stock plummets to multiyear lows, it's typically not a good sign for the business and its investors. It can signal that there's something deeply wrong with the business, its fundamentals,

Shares of apparel company Lululemon Athletica (NASDAQ: LULU) have been in a tailspin this year, down more than 50% to levels they haven't been at since 2020. It has been one of the worst-performing

Image source: The Motley Fool.

Wednesday, December 10, 2025 at 5:00 p.m. ET

Need a quote from a Motley Fool analyst? Email [email protected]

Continue reading

Source Fool.com

Motley Fool co-founder and CEO Tom Gardner and analyst Seth Jason recently talked with Rocket Lab founder and CEO Peter Beck about business, engineering, and entrepreneurship.

To catch full episodes

In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down the latest competing deals for Warner Bros. Discovery (NASDAQ: WBD), between the agreed-upon deal with Netflix (NASDAQ:

Robinhood Markets (NASDAQ: HOOD) is having a stellar year, and so are its shareholders. As of Dec. 9, Robinhood shares are up nearly 90% over the past six months, and they've soared 270% in 2025

Picking between XRP (CRYPTO: XRP) and Cardano (CRYPTO: ADA) is really a choice between investing in a chain that wants to be plumbing for global money flows, and a chain that still feels like an

Barry Ticho, Chief Medical Officer at Stoke Therapeutics (NASDAQ:STOK), executed an option exercise and open-market sale of 5,358 common shares for a total consideration of approximately $167,115 on